Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul><li>Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets.</li><li> Cosmos Health announced initial sales results from their recently introduced US subscription business.</li><li> Initial signs are extremely encouraging and show accelerating growth prospects.</li></ul>

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health announced initial sales results from their recently introduced US subscription business. Initial signs are extremely encouraging and show accelerating growth prospects.

COSM: More Evidence of Accelerating Growth

<ul><li>Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets.</li><li> Cosmos Health had two announcements that further demonstrates the improving growth trajectory for the company and why investors are missing an improving investment opportunity.</li></ul>

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health had two announcements that further demonstrates the improving growth trajectory for the company and why investors are missing an improving investment opportunity.

<ul><li>Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets.</li><li> Cosmos Health announced the launch of C-ScrubVet with the first commercial orders, entering the massive animal health care market and further solidifying its growth strategy.</li></ul>

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health announced the launch of C-ScrubVet with the first commercial orders, entering the massive animal health care market and further solidifying its growth strategy.

COSM: Launch Reinforced Company's Growth Strategy

<ul><li>Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets.</li><li> Cosmos Health has announced record revenues, expanded business and impressive share buyback numbers and investors should start to pay attention.</li></ul>

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health has announced record revenues, expanded business and impressive share buyback numbers and investors should start to pay attention.

COSM: Business Transforming into Rapid Grower

United States

Cosmos Health, Inc. operates as a pharmaceutical company. The Company identifies, acquires, develops, and commercializes generic pharmaceuticals, nutraceuticals, OTC medications, and medical devices that improve patients lives and outcomes. Cosmos Health serves patients worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Cosmos Health (COSM US)

COSM: More Evidence of Accelerating Growth

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical...

Zacks Small Cap Research

COSM: Growth Continues to Impress

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical...

Zacks Small Cap Research

COSM: Launch Reinforced Company's Growth Strategy

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical...

Zacks Small Cap Research

COSM: Business Transforming into Rapid Grower

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical...

Zacks Small Cap Research

COSM: Hitting on All Cylinders

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)